CEREBRAL PERFUSION PRESSURE-GUIDED THERAPY AFTER TRAUMATIC BRAIN INJURY
The impetus for cerebral hemodynamic monitoring in neurotrauma first arose from the original “talk and die” studies that described a group of head-injured patients “who talked and then subsequently died.”1 At necropsy, hypoxic or ischemic brain damage was observed in a variable proportion of patients raising the possibility that systemic or cerebral hypoxia after trauma may have contributed to the poor neurological outcome.2,3 Data from the studies of Bouma et al., and Jaggi et al., also demonstrated an inverse relationship between cerebral blood flow (CBF) and neurological outcome after traumatic brain injury (TBI).4,5 The Traumatic Coma Data Bank study reaffirmed the importance of hypoxia and hypotension in determining outcome from neurotrauma.6–8 Improved understanding of the pathophysiology of neurotrauma influenced clinical practice in two ways: a) a plethora of monitoring modalities were developed for evaluating cerebral hemodynamics and oxygenation and b) squeezing oxygenated blood through a swollen brain by increasing arterial blood pressure (BP) became the cornerstone of therapy in patients with TBI.
Understanding the physiology of cerebral oxygenation is critical to the development of effective management strategies for limiting cerebral insults after injury. The three main factors determining cerebral oxygenation are CBF, arterial oxygen content and cerebral metabolic rate of oxygen consumption (CMRO2).9,10 In clinical practice, monitoring of arterial blood gas tensions is routine in most critically ill patients. CMRO2 measurement is not commonplace as it is technically cumbersome and difficult to manipulate in clinical practice. Similarly, the routine measurement of CBF (e.g., nitrous oxide or the Xenon 133 radiotracer) is not practical in the intensive care unit.11,12 The cerebral perfusion pressure (CPP) is the most frequently used surrogate for CBF measurements. CPP is easily performed, provides a continuous measurement and forms part of the management guidelines of the Brain Trauma Foundation (BTF).13–15 However, the optimal CPP threshold continues to generate controversy.
This article will review the concept of “optimal CPP,” and examine its relationship to CBF, metabolism, brain tissue oxygenation and neurological outcome.
THE BASIC PHYSIOLOGY
Physiological Factors Affecting Cerebral Perfusion Pressure
CPP is the difference between the mean arterial BP (MAP) and the intracranial pressure (ICP). It represents the vascular pressure gradient across the cerebral beds and should be measured at the same level. CBF is determined by both CPP and cerebrovascular resistance (CVR) as shown: CBF = CPP/CVR.9,16,17 CVR (and thus CBF) are affected by a number of physiological variables including arterial carbon dioxide gas tension (PAco2), which has a near linear relationship with CBF within the physiological range (producing a 2%–4% increase of CBF for each millimeter of mercury of PAco2 increase), and cerebral metabolic rate for oxygen and glucose which has a direct relationship with CBF.18
Under normal circumstances, the brain is able to maintain a relatively constant CBF of approximately 50 mL per 100 g/min over a wide range of CPP (approximately 60 to 150 mm Hg).19 This process termed “autoregulation” is a fundamental physiological premise governing the CPP/CBF relationship.
Autoregulation can be defined as the inherent ability of arteries to vasodilate or vasoconstrict in response to changing perfusion pressure, thereby maintaining a relatively stable CBF (Fig. 1). Metabolic, myogenic, and neurogenic mechanisms have been invoked to explain control of autoregulation.20–22
Autoregulation can become impaired or abolished by a variety of insults including trauma, hypoxemia, hypercapnia, and large-dose volatile anesthetics.23 This is not an all-or-none phenomenon, but is a continuous spectrum of adaptive response in CVR to a change in perfusion pressure and may vary from region to region. In patients with preserved autoregulation, an increase of MAP may be beneficial as the compensatory vasoconstriction mediated by the autoregulatory response would result in a decrease in ICP.24 Moreover, some TBI patients have a rightward shifted lower limit of autoregulation, necessitating the maintenance of a higher MAP than normal.25 It has therefore been suggested that evaluation of the cerebral autoregulatory (CA) capacity may facilitate clinical management of these patients.
Several dynamic and static tests for autoregulation are commonly used in patients with neurotrauma including the autoregulatory index, the transient hyperemic response test and the pressure reactivity index. A detailed description of these tests is outside of the scope of this article and the reader is referred to References.26–29
There have been a number of clinical studies examining autoregulation after TBI. Czosnyka et al.30 have demonstrated a correlation between impaired autoregulation and poor neurological outcome in patients with TBI. Autoregulation was noted to be abnormal within the first 2 days after injury and often asymmetrical (different between the two hemispheres). They were able to identify individual thresholds of vascular reactivity for CPP, ICP and ventilator variables. Some authors have suggested that management should be altered depending on the ability to identify a lower inflection point on the CA curve.31,32 The implication is that CPP should be kept greater than this point when CA is intact, whereas other end-points should be used to titrate CPP when CA is absent (i.e., jugular venous oxygen saturation (SjVO2), cerebral oxygen measurement, etc.).
There are data to support individualizing treatment strategies based on the state of autoregulation. Steiner et al.32 used the pressure reactivity index to define an optimal CPP for each individual based on the premise that the autoregulatory range varies among patients. Howells et al.31 compared CPP to ICP-directed therapy in two Groups of patients with TBI. They concluded that ICP-orientated therapy led to better outcomes in pressure-passive patients, whereas hypertensive CPP therapy was better in patients with intact autoregulation.
Is There A Critical Cerebral Perfusion Pressure Threshold in Traumatic Brain Injury?
As autoregulation may be impaired early after TBI, the problem is setting a single goal for CPP in a heterogeneous group of patients with differing levels of autoregulation. Several end-points have been used to define the target CPP, including the relationship between CPP and CBF, and CPP and brain tissue metabolites. These are discussed briefly below.
The critical threshold of CBF for the development of irreversible tissue damage after TBI is 15 mL 100 g/min.33 The corresponding figure after ischemic stroke is 5–8.5 mL 100 g/min. As techniques for measuring CBF are largely experimental, most clinicians use CPP as a surrogate. Chieregato et al. demonstrated poor correlation between global CBF and different CPP ranges in severe head injury.34 This was attributed to preserved autoregulation in their study group. Conversely, Czosnyka et al.28 demonstrated impaired autoregulation in patients with TBI, making it difficult to derive a relationship between CPP and CBF.
Given this heterogeneity, interpreting results from clinical outcome studies can be difficult. Researchers have therefore investigated the physiological impact of CPP on a variety of cerebral tissue metabolites. The three metabolic end-points investigated in detail include brain tissue oxygenation, positron emission tomography (PET) scan and cerebral microdialysis. The major limitations of the metabolite approach include the controversy on the ideal area for sampling and the limited ability to extract global conditions from local data. Nevertheless, cerebral metabolite examination provides some indication of the impact that changes in CPP have on brain function.
Cerebral Perfusion Pressure Versus Tissue Oxygenation
Cerebral oxygenation can be assessed both globally using SjVO2 monitoring or locally using brain tissue oxygen tension (PbO2)probes. SjVO2 (jugular bulb venous oxygen saturation) is a function of the arterial oxygen saturation, CBF and CMRO2. Under conditions of stable cerebral metabolism, changes in SjVO2 reflect changes in CBF. Normal values range from 55%–75%. There is evidence that jugular venous desaturation is associated with poor neurological outcome.35 However, this technique has not found uniform acceptance among intensivists because of its invasive nature, the difficulty in identifying the appropriate side for cannulation, and erroneous readings resulting from catheter malposition, impaction and thrombus formation.36 SjVO2 has been found to correlate strongly with tissue Po2 in the normal brain, but not in the contused brain.37 It is an index of CBF only if CMRO2 is assumed to be constant.
PbO2 probes measure the partial pressure of oxygen in the extracellular compartment of the brain, which is the balance between oxygen delivery and consumption and is influenced by changes in capillary perfusion. Hypoxic thresholds vary according to placement of probe and physiological conditions. Positioning is critical as sampling occurs in an area of approximately 15 mm2 around the probe.
A number of studies have examined the relationship between CPP and cerebral oxygenation. Cruz et al. failed to demonstrate a relationship between CPP and CMRO2, SjVO2 or CBF over a broad range of CPP (60–130 mm Hg).38 Similarly, Sahuquillo et al.39 were unable to demonstrate a linear relationship between CPP and low PbO2. PbO2 readings less than 15 mm Hg were noted with both normal and supranormal CPPs. Moreover, therapy targeted at improving PbO2 may not necessarily correlate with CPP. Steifel et al. demonstrated that, although PbO2-directed therapy led to improved outcomes, CPP was similar between the groups.40 Not all interventions that increase CPP (i.e., vasopressors, mannitol, and hyperventilation) have equal effects on PbO2. The effects of vasopressors on cerebral oxygen metabolism are variable. In general, once CPP is less than the autoregulatory range, cerebral oxygenation worsens. The level at which this occurs appears to vary and may represent differences in autoregulation.41–52 (Table 1).
Cerebral Perfusion Pressure Versus Positron Emission Tomography
PET is an imaging technique that can estimate CBF, cerebral blood volume, CMRO2 and oxygen extraction fraction (OEF). This technology can be used to assess the impact of changes to CPP on cerebral oxygenation.
Johnston et al. investigated whether augmentation of CPP improved CBF and tissue oxygenation as assessed by PbO2 and microdialysis.45 They found that CPP changes (70–90 mm Hg) correlated with tissue oxygenation and CBF, but not with microdialysis variables (glucose, lactate, pyruvate, and glycerol). This supports the observation that changes in cerebral oxygen supply do not always correlate with metabolic requirements. The findings of Coles et al. were similar to that of Johnston et al. CPP increases (68–90 mm Hg)53 were associated with an increase in CBF and decrease in CMRO2 and OEF, mainly in patients with a large ischemic burden. Steiner et al.54 using PET examined the pericontusional response to increasing CPP in 18 patients with TBI. They found the maximum increase in CBF in the normal brain with minimal increase in the ischemic areas. These studies once again reaffirm the view that, although increasing CPP may improve cerebral oxygenation, the results are by no means universal and vary depending on the area of brain examined.
Cerebral Perfusion Pressure Versus Microdialysis
Cerebral microdialysis (using a catheter ideally placed in the frontal lobe)55 is a tool for investigating the metabolic status of the injured brain. Interstitial glucose, lactate and pyruvate concentration provide direct information about glucose delivery and utilization, whereas the lactate/pyruvate ratio reflects the intracellular redox state. Furthermore, pH, glycerol (an index of cell membrane breakdown) and glutamate (a measure of cerebral excitotoxicity) can also be measured. Studies examining the relationship between CPP and metabolic end-points have produced conflicting results.
Nordstrom studied brain tissues with varying degrees of injury.56 He demonstrated that lactate in the more injured brain increased when CPP <50 mm Hg but also when CPP >70 mm Hg. There was little change in the normal brain. He surmised that this was due to differences in regional blood flow characteristics. Stahl et al. demonstrated that reducing CPP led to a progressive normalization of microdialysis constituents as long as CPP was >50 mm Hg but that less than this threshold, significant ischemia developed.57
In two separate studies, Johnston et al. attempted to measure the effect of artificially increasing CPP with vasopressors on measures of tissue oxygenation and metabolism including microdialysis.45,46 Despite evidence of improved CBF and oxygenation, there was no significant change in microdialytic indices. Conversely, Hlatky et al. found a significant increase in microdialysis lactate and pyruvate in a subgroup of patients with TBI who developed focal delayed traumatic injury.58 This occurred in the absence of global changes in ICP, CPP, and SjVO2.
Although there seems to be a relationship between CPP and oxygen metabolism in the injured brain, the optimal level of CPP is difficult to determine. It is also unclear whether to monitor the injured or normal cerebral tissue. Further studies using multimodal monitoring techniques may clarify the situation.
CONTROVERSIES OF CEREBRAL PERFUSION-TARGETED THERAPY IN NEUROTRAUMA
As noted, optimizing cerebral perfusion continues to generate controversy. Three broad approaches have been proposed: CPP-targeted approach, CBF/ICP-targeted approach, and maintenance of cerebral volume/CPP approach. (Table 2).
Cerebral Perfusion Pressure-Based Therapy
Rosner et al. were among the first to study the effects of aggressively managing CPP.25 The main tenets of their theory are that autoregulation after TBI is preserved but shifted to the right, therefore a higher CPP is required to obtain adequate CBF. Increasing CPP can also minimize ICP by reducing intracranial blood volume and cerebral edema through autoregulatory vasoconstriction. Thus, by stabilizing CPP at higher levels, they suggested that ICP could be better controlled without ischemia.
To support their theory, they undertook a nonrandomized study of 158 TBI patients presenting with a Glascow Coma Scale (GCS) score of <7.25 A combination of cerebrospinal fluid drainage, vasopressors (phenylephrine and dopamine) and mannitol was used to keep CPP >70 mm Hg. CPP could be increased to 80–90 mm Hg under certain conditions. The average GCS on admission was five. The mortality rate was 29% with a favorable recovery at 10.5 mo in 59% (Glascow Outcome Scale score 4–5) of patients. This compared favorably with outcomes from the Traumatic Coma Data Bank. During the study, the average ICP was 27 ± 12 mm Hg for the first 10 days and 25 ± 12 mm Hg for the entire course. The mean CPP was greater than 80 mm Hg.
Based on their results, the authors argued that a) the injured brain requires a CPP more than normal before adequate CBF can be attained, b) ICP-based therapy is transient, toxic and should be used sparingly, c) TBI injury shifts the CA curve to the right which explains the finding of dysautoregulation in older studies (i.e., CPP not high enough), and d) autoregulation is not completely absent, therefore increasing CPP will lead to decrease ICP.
Cerebral Blood Flow/Oxygen Extraction Coupling Theory
Cruz argued that patients with TBI present with pathologically reduced levels of cerebral oxygen consumption as indicated by reduced cerebral oxygen extraction leading to relative cerebral hyperperfusion.59 As cerebral hyperperfusion has been associated with worse outcome, optimized hyperventilation may improve CBF/oxygen extraction coupling, normalizing ICP. He further argued that Rosner et al. did not assess CBF, cerebral blood volume or oxygen extraction when determining vasodilatory cascade, only ICP and BP, leading to the erroneous conclusion that autoregulation is intact in most patients.
Cruz et al. performed two nonrandomized studies to examine the CBF/oxygen extraction-coupling hypothesis. In the first, they investigated 66 adults with severe TBI.38 There was no correlation between CPP and CBF, atriovenous oxygen content difference and cerebral oxygen consumption. Furthermore, reduced CBF was associated with normal OEF supporting reduced cerebral metabolism and luxury perfusion.
Cruz subsequently prospectively compared the outcome of patients undergoing monitoring and management of oxygen extraction with CPP (CPPe) (n = 178) versus CPP alone (n = 175).59 The mortality rate in the extraction group (9%) was significantly less than the CPP group (30%). The duration of ICP monitoring was only 6.5 days in the CPPe group versus 10.5 in the CPP group and the CPPe group had overall better outcome. There are, however, no data comparing CPP and ICP during the study period. Cruz argued that TBI leads to relative hyperperfusion after 12 hrs. Furthermore, CPPe shortens the period of hyperemia and thus the length of time needed for monitoring.
Management of Cerebral Volume and Perfusion
The Lund approach is based on the observation that in normal individuals, the blood–brain barrier creates an osmotic gradient between the cerebral tissue and the intravascular compartment, regulating the movement of fluid across the membrane.60 However after head injury, blood–brain barrier permeability increases reducing the effectiveness of the brain’s normal volume-regulating mechanisms. Consequently, forces other than the crystalloid transcapillary force control brain volume (e.g., capillary hydrostatic and plasma oncotic pressure). Furthermore, autoregulation is often impaired causing an increase in arterial pressure which leads to an increase in CBF and capillary hydrostatic pressure, worsening cerebral edema and intracranial hypertension.
The main tenets of the Lund approach include
1. Reduction of capillary hydrostatic pressure by reducing systemic pressure using β – blockade, α antagonist and angiotensin II inhibition
2. Maintenance of normovolemia and colloid osmotic pressure with 20% albumin and blood
3. Prevention of cerebral vasoconstriction by maintaining cerebral oxygenation and avoiding hyperventilation and cerebral vasoconstrictors
There have been four small nonrandomized studies evaluating Lund therapy in adults after TBI.61–64 Asgeirsson et al. described a case series of 11 severely injured patients with a GCS <8, impaired cerebral reactivity to hyperventilation and computed tomography scan consistent with diffuse injury.61 Nine patients had good/moderate disability and two died. The authors suggested that similar groups have shown mortality rates of 100%.
Another study by Eker et al. compared Lund therapy in a group of 53 patients with severe TBI, GCS <8 and ICP >25 mm Hg with historical controls who were treated according to conventional principles.62 Patients were managed according to the above principles and, although a CPP of >60 mm Hg was preferable, 50 mm Hg was acceptable where necessary to maintain ICP <25 mm Hg. Eight percent of patients died and the neurologic conditions of 13% remained severely damaged, compared with 47% and 11%, respectively, for the control group.
According to the authors, despite not being randomized, patients were well matched to historical controls and comparable to results from other units. CPPs as low as 50 mm Hg were well tolerated in their patients and led to decreased cerebral swelling. Overall, the outcomes were good compared to similar cohort studies.
The advocates of the Lund protocol suggest a) outcomes from CPP-targeted therapy are worse than Lund therapy, b) hypotension as a predictor of poor outcome is largely due to hypovolemia whereas they maintained normovolemia, c) optimal CPP should be individualized depending on age, ICP, plasma oncotic pressure and CVR, and d) an increase in ICP can be counteracted by early initiation of therapy.
BRAIN TRAUMA FOUNDATION AND CEREBRAL PERFUSION PRESSURE GUIDELINES
There is good evidence that CPP is low after TBI.65,66 Certainly postmortem data suggest that cerebral ischemia is common in those who die. Several studies have documented worsened outcome in TBI patients who have experienced episodes of hypotension (systolic BP <90 mm Hg) in the first few hours after injury.6,67–71 Thus, continuous monitoring and manipulation of CPP has become an integral part of the management of TBI.
The ideal CPP is controversial.72 CBF requirements and autoregulation are different in injured compared to noninjured cerebral regions leading to varying susceptibility to ischemia. The initial 1995 BTF recommendations advocating a CPP of 70 mm Hg have been criticized as they were not based on randomized controlled trials (RCTs) and maintenance of CPP was often not the primary focus13,14,25,67,72–78 (Table 3). Subsequent studies have challenged this approach based on several lines of evidence: a) the higher risk of acute respiratory distress syndrome (ARDS) in patients who are treated with pressors to achieve target CPP79 (logistic regression suggested that induced hypertension was the main factor leading to ARDS80), b) the finding that patients who developed ARDS experienced a 2.5-fold increase in refractory intracranial hypertension and were more likely to be in a vegetative state or dead at 6 mo postinjury, and c) the demonstration of a plateau in brain tissue Po2 at a CPP of 60 mm Hg.48
The data from Juul et al. examining patients enrolled in the Selfotel trial81 also suggested that the critical CPP threshold was 60 mm Hg. There was no independent effect on neurologic outcomes for patients who had CPPs higher than 60 mm Hg. Based on the above data, the BTF revised their guidelines to advocate a goal CPP of 60 mm Hg rather then 70 mm Hg. The 2007 BTF guidelines have further refined their recommendations considering the growing body of evidence that suggests CPP-based therapy should be adapted to reflect the state of autoregulation in a given patient.15,82 This was largely based on the work of Howells et al. and Steiner et al. as previously described.31,32 Balestreri et al.83 subsequently confirmed the dangers of excessively high or low CPP. While continuing to note the dangers of a CPP >70 or <50 mm Hg, the recommendation is to use ancillary monitoring of cerebral oxygenation and metabolism to individualize therapy within the CPP range of 50–70 mm Hg.
There is little high quality evidence to support CPP-based management in pediatric TBI patients. There are no RCTs. However, a retrospective cohort, class II study by Downard et al.84 found that mortality rate was significantly associated with a mean CPP <40 mm Hg (P < 0.01) and mean ICP >20 mm Hg (P < 0.001). There was no incremental reduction in the mortality rate or improved 3-mo Glascow Outcome Scale score associated with mean increases of CPP >40 mm Hg. Several small nonrandomized studies have found similar results.85–87 The International Brain Injury Association Guidelines have recommended a perfusion pressure of >40 mm Hg in children with TBI.88 They further noted that a CPP between 40 and 65 mm Hg is an age-related continuum for the optimal treatment threshold.
Few RCTs have examined the relationship between CPP and outcome. Juul et al. examined physiological data from the Selfotel study,81 a RCT of 427 severe TBI patients randomized to receive either N-methyl-d-aspartate antagonists or placebo. They failed to find a relationship between outcome and CPP if CPP >60 mm Hg, but noted a strong relationship between outcome and ICP >20 mm Hg. ICP not CPP was the major risk factor for neurological deterioration.
Huang et al.89 retrospectively compared three techniques for managing ICP/CPP. The first was ICP based, the second CPP with target >70 mm Hg and the third was CPP with target >60 mm Hg. They found similar results to previous studies. CPP-based therapy improves outcome compared to ICP and CPP >60 mm Hg is comparable to CPP >70 mm Hg with fewer complications. This study has a number of limitations. It is retrospective, the ICP group was hyperventilated to CO2 <25 mm Hg if needed (in excess of BTF recommendations), and CPP was maintained at 50 mm Hg and the patients managed in a negative fluid balance. Consequently, their data are difficult to interpret.
Several studies have included CPP/ICP data in their analysis. The phase II study of dexanabinol, a synthetic nonpsychotropic cannabinoid included 67 severe TBI adults and found the percentage of patients with a good outcome at 3 and 6 mo was 21% and 14% higher than control.90 This appeared at least partly due to a significant reduction in percentage of time ICP >25 mm Hg, CPP <50 mm Hg and MAP <90 mm Hg. However, the subsequent phase III study, in 861 patients with TBI found no difference in outcome, ICP or CPP.91 Cooper et al.92 examined 229 patients with TBI who received hypertonic saline versus Ringer’s solution pre-hospital admission. There was no difference in outcome between the groups despite near significant differences in the duration of CPP <70 mm Hg (9.5 vs 17 hrs in control (P = 0.06)).
In summary, there is little evidence from RCTs to support a specific CPP target. It is surprising that, until recently, CPP was not regarded as an important consideration in trial design or data interpretation. Future researchers need to include ICP and CPP data to ensure experimental groups are well matched.
Experimental and clinical evidence suggests that a low CPP is potentially harmful after TBI. What is less clear is the optimal CPP for a given patient. Although some would argue that the higher the better, artificially increasing CPP has repeatedly been shown to be harmful and may actually worsen outcome. Further complicating the issue is that optimal CPP may vary from patient to patient and over time as the physiological environment of the injured brain changes, prompting the need for a more individualized approach. This idea has merit but needs further investigation before being adopted as standard of care. Until then, we would suggest following the BTF CPP guidelines target of 50 mm Hg −70 mm Hg as a compromise in the knowledge that CPP is only one aspect in the complex management of TBI.
1. Reilly PL, Graham DI, Adams JH, Jennett B. Patients with head injury who talk and die. Lancet 1975;2:375–7
2. Marshall LF, Toole BM, Bowers SA. The national traumatic coma data bank. Part 2: patients who talk and deteriorate: implications for treatment. J Neurosurg 1983;59:285–8
3. Graham DI, Adams JH. Ischaemic brain damage in fatal head injuries. Lancet 1971;1:265–6
4. Bouma GJ, Muizelaar JP. Cerebral blood flow in severe clinical head injury. New Horiz 1995;3:384–94
5. Jaggi JL, Cruz J, Gennarelli TA. Estimated cerebral metabolic rate of oxygen in severely brain-injured patients: a valuable tool for clinical monitoring. Crit Care Med 1995;23:66–70
6. Chesnut RM, Marshall SB, Piek J, Blunt BA, Klauber MR, Marshall LF. Early and late systemic hypotension as a frequent and fundamental source of cerebral ischemia following severe brain injury in the traumatic coma data bank. Acta Neurochir Suppl (Wien) 1993;59:121–5
7. Obrist WD, Langfitt TW, Jaggi JL, Cruz J, Gennarelli TA. Cerebral blood flow and metabolism in comatose patients with acute head injury. Relationship to intracranial hypertension. J Neurosurg 1984;61:241–53
8. Ruff RM, Marshall LF, Crouch J, Klauber MR, Levin HS, Barth J, Kreutzer J, Blunt BA, Foulkes MA, Eisenberg HM, et al. Predictors of outcome following severe head trauma: follow-up data from the traumatic coma data bank. Brain Inj 1993;7:101–11
9. Harper AM. Physiology Of cerebral bloodflow. Br J Anaesth 1965;37:225–35
10. Kety SS, Hafkenschiel JH, Jeffers WA, Leopold IH, Shenkin HA. The blood flow, vascular resistance, and oxygen consumption of the brain in essential hypertension. J Clin Invest 1948;27:511–14
11. Kety SS, Schmidt CF. The nitrous oxide method for the quantitative determination of cerebral blood flow in man: theory, procedure and normal values. J Clin Invest 1948;27:476–83
12. Kety SS. Study of the cerebral circulation by means of inert diffusible tracers. Prog Brain Res 1972;35:375–85
13. Guidelines for cerebral perfusion pressure. Brain Trauma Foundation. J Neurotrauma 1996;13:693–7
14. The Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Guidelines for cerebral perfusion pressure. J Neurotrauma 2000;17:507–11
15. Guidelines for the management of severe traumatic brain injury. IX. Cerebral perfusion thresholds. J Neurotrauma 2007;24(suppl 1):S59–S64
16. Lassen NA. Cerebral blood flow and oxygen consumption in man. Physiol Rev 1959;39:183–238
17. Lassen NA. Control of cerebral circulation in health and disease. Circ Res 1974;34:749–60
18. Vavilala MS, Lee LA, Lam AM. Cerebral blood flow and vascular physiology. Anesthesiol Clin North America 2002;20:247–64
19. Steiner LA, Andrews PJ. Monitoring the injured brain: ICP and CBF. Br J Anaesth 2006;97:26–38
20. Bayliss WM. On the local reactions of the arterial wall to changes of internal pressure. J Physiol 1902;28:220–31
21. Jones SC, Radinsky CR, Furlan AJ, Chyatte D, Perez-Trepichio AD. Cortical NOS inhibition raises the lower limit of cerebral blood flow-arterial pressure autoregulation. Am J Physiol 1999;276:H1253—H1262
22. Morillo CA, Ellenbogen KA, Fernando Pava L. Pathophysiologic basis for vasodepressor syncope. Cardiol Clin 1997;15:233–49
23. McCulloch TJ, Visco E, Lam AM. Graded hypercapnia and cerebral autoregulation during sevoflurane or propofol anesthesia. Anesthesiology 2000;93:1205–9
24. Baguley IJ, Nicholls JL, Felmingham KL, Crooks J, Gurka JA, Wade LD. Dysautonomia after traumatic brain injury: a forgotten syndrome? J Neurol Neurosurg Psychiatry 1999;67:39–43
25. Rosner MJ, Rosner SD, Johnson AH. Cerebral perfusion pressure: management protocol and clinical results. J Neurosurg 1995;83:949–62
26. Aaslid R, Lindegaard KF, Sorteberg W, Nornes H. Cerebral autoregulation dynamics in humans. Stroke 1989;20:45–52
27. Aaslid R, Newell DW, Stooss R, Sorteberg W, Lindegaard KF. Assessment of cerebral autoregulation dynamics from simultaneous arterial and venous transcranial Doppler recordings in humans. Stroke 1991;22:1148–54
28. Czosnyka M, Smielewski P, Kirkpatrick P, Laing RJ, Menon D, Pickard JD. Continuous assessment of the cerebral vasomotor reactivity in head injury. Neurosurgery 1997;41:11–17
29. Giller CA. A bedside test for cerebral autoregulation using transcranial Doppler ultrasound. Acta Neurochir (Wien) 1991;108:7–14
30. Czosnyka M, Smielewski P, Kirkpatrick P, Piechnik S, Laing R, Pickard JD. Continuous monitoring of cerebrovascular pressure-reactivity in head injury. Acta Neurochir Suppl 1998;71:74–7
31. Howells T, Elf K, Jones PA, Ronne-Englstrom E, Piper I, Nilsson P, Andrews P, Enblad P. Pressure reactivity as a guide in the treatment of cerebral perfusion pressure in patients with brain trauma. J Neurosurg 2005;102:311–17
32. Steiner LA, Czosnyka M, Piechnik SK, Smielewski P, Chatfield D, Menon DK, Pickard JD. Continuous monitoring of cerebrovascular pressure reactivity allows determination of optimal cerebral perfusion pressure in patients with traumatic brain injury. Crit Care Med 2002;30:733–8
33. Cunningham AS, Salvador R, Coles JP, Chatfield DA, Bradley PG, Johnston AJ, Steiner LA, Fryer TD, Aigbirhio FI, Smielewski P, Williams GB, Carpenter TA, Gillard JH, Pickard JD, Menon DK. Physiological thresholds for irreversible tissue damage in contusional regions following traumatic brain injury. Brain 2005;128:1931–42
34. Chieregato A, Fainardi E, Tanfani A, Sabia G, Martino C, Pascarella R, Servadei F, Targa L. Induced acute arterial hypertension and regional cerebral flow in intracontusional low density area. Acta Neurochir Suppl 2003;86:361–5
35. Gopinath SP, Robertson CS, Contant CF, Hayes C, Feldman Z, Narayan RK, Grossman RG. Jugular venous desaturation and outcome after head injury. J Neurol Neurosurg Psychiatry 1994;57:717–23
36. Feldman Z, Robertson CS. Monitoring of cerebral hemodynamics with jugular bulb catheters. Crit Care Clin 1997;13:51–77
37. Gopinath SP, Valadka AB, Uzura M, Robertson CS. Comparison of jugular venous oxygen saturation and brain tissue Po2 as monitors of cerebral ischemia after head injury. Crit Care Med 1999;27:2337–45
38. Cruz J, Jaggi JL, Hoffstad OJ. Cerebral blood flow, vascular resistance, and oxygen metabolism in acute brain trauma: redefining the role of cerebral perfusion pressure? Crit Care Med 1995;23:1412–17
39. Sahuquillo J, Amoros S, Santos A, Poca MA, Panzardo H, Dominguez L, Pedraza S. Does an increase in cerebral perfusion pressure always mean a better oxygenated brain? A study in head-injured patients. Acta Neurochir Suppl 2000;76:457–62
40. Stiefel MF, Udoetuk JD, Spiotta AM, Gracias VH, Goldberg A, Maloney-Wilensky E, Bloom S, Le Roux PD. Conventional neurocritical care and cerebral oxygenation after traumatic brain injury. J Neurosurg 2006;105:568–75
41. al-Rawi PG, Hutchinson PJ, Gupta AK, Piechnik SK, Pickard JD, Kirkpatrick PJ. Multiparameter brain tissue monitoring–correlation between parameters and identification of CPP thresholds. Zentralbl Neurochir 2000;61:74–9
42. Bruzzone P, Dionigi R, Bellinzona G, Imberti R, Stocchetti N. Effects of cerebral perfusion pressure on brain tissue PO2 in patients with severe head injury. Acta Neurochir Suppl 1998;71:111–13
43. Chan KH, Miller JD, Dearden NM, Andrews PJ, Midgley S. The effect of changes in cerebral perfusion pressure upon middle cerebral artery blood flow velocity and jugular bulb venous oxygen saturation after severe brain injury. J Neurosurg 1992;77:55–61
44. Fortune JB, Feustel PJ, Weigle CG, Popp AJ. Continuous measurement of jugular venous oxygen saturation in response to transient elevations of blood pressure in head-injured patients. J Neurosurg 1994;80:461–8
45. Johnston AJ, Steiner LA, Chatfield DA, Coles JP, Hutchinson PJ, Al-Rawi PG, Menon DK, Gupta AK. Effect of cerebral perfusion pressure augmentation with dopamine and norepinephrine on global and focal brain oxygenation after traumatic brain injury. Intensive Care Med 2004;30:791–7
46. Johnston AJ, Steiner LA, Coles JP, Chatfield DA, Fryer TD, Smielewski P, Hutchinson PJ, O’Connell MT, Al-Rawi PG, Aigbirihio FI, Clark JC, Pickard JD, Gupta AK, Menon DK. Effect of cerebral perfusion pressure augmentation on regional oxygenation and metabolism after head injury. Crit Care Med 2005;33:189–95, discussion 255–7
47. Kiening KL, Hartl R, Unterberg AW, Schneider GH, Bardt T, Lanksch WR. Brain tissue pO2-monitoring in comatose patients: implications for therapy. Neurol Res 1997;19:233–40
48. Lang EW, Czosnyka M, Mehdorn HM. Tissue oxygen reactivity and cerebral autoregulation after severe traumatic brain injury. Crit Care Med 2003;31:267–71
49. Marin-Caballos AJ, Murillo-Cabezas F, Cayuela-Dominguez A, Dominguez-Roldan JM, Rincon-Ferrari MD, Valencia-Anguita J, Flores-Cordero JM, Munoz-Sanchez MA. Cerebral perfusion pressure and risk of brain hypoxia in severe head injury: a prospective observational study. Crit Care 2005;9:R670–R676
50. Meixensberger J, Jaeger M, Vath A, Dings J, Kunze E, Roosen K. Brain tissue oxygen guided treatment supplementing ICP/CPP therapy after traumatic brain injury. J Neurol Neurosurg Psychiatry 2003;74:760–4
51. Reinert M, Barth A, Rothen HU, Schaller B, Takala J, Seiler RW. Effects of cerebral perfusion pressure and increased fraction of inspired oxygen on brain tissue oxygen, lactate and glucose in patients with severe head injury. Acta Neurochir (Wien) 2003;145:341–9
52. Stiefel MF, Udoetuk JD, Storm PB, Sutton LN, Kim H, Dominguez TE, Helfaer MA, Huh JW. Brain tissue oxygen monitoring in pediatric patients with severe traumatic brain injury. J Neurosurg 2006;105:281–6
53. Coles JP, Steiner LA, Johnston AJ, Fryer TD, Coleman MR, Smieleweski P, Chatfield DA, Aigbirhio F, Williams GB, Boniface S, Rice K, Clark JC, Pickard JD, Menon DK. Does induced hypertension reduce cerebral ischaemia within the traumatized human brain? Brain 2004;127:2479–90
54. Steiner LA, Coles JP, Johnston AJ, Czosnyka M, Fryer TD, Smielewski P, Chatfield DA, Salvador R, Aigbirhio FI, Clark JC, Menon DK, Pickard JD. Responses of posttraumatic pericontusional cerebral blood flow and blood volume to an increase in cerebral perfusion pressure. J Cereb Blood Flow Metab 2003;23:1371–7
55. Bellander BM, Cantais E, Enblad P, Hutchinson P, Nordstrom CH, Robertson C, Sahuquillo J, Smith M, Stocchetti N, Ungerstedt U, Unterberg A, Olsen NV. Consensus meeting on microdialysis in neurointensive care. Intensive Care Med 2004;30:2166–9
56. Nordstrom CH. Assessment of critical thresholds for cerebral perfusion pressure by performing bedside monitoring of cerebral energy metabolism. Neurosurg Focus 2003;15:E5
57. Stahl N, Ungerstedt U, Nordstrom CH. Brain energy metabolism during controlled reduction of cerebral perfusion pressure in severe head injuries. Intensive Care Med 2001;27:1215–23
58. Hlatky R, Valadka AB, Goodman JC, Contant CF, Robertson CS. Patterns of energy substrates during ischemia measured in the brain by microdialysis. J Neurotrauma 2004;21:894–906
59. Cruz J. The first decade of continuous monitoring of jugular bulb oxyhemoglobinsaturation: management strategies and clinical outcome. Crit Care Med 1998;26:344–51
60. Grande PO. The “Lund Concept” for the treatment of severe head trauma–physiological principles and clinical application. Intensive Care Med 2006;32:1475–84
61. Asgeirsson B, Grande PO, Nordstrom CH. A new therapy of post-trauma brain oedema based on haemodynamic principles for brain volume regulation. Intensive Care Med 1994;20:260–7
62. Eker C, Asgeirsson B, Grande PO, Schalen W, Nordstrom CH. Improved outcome after severe head injury with a new therapy based on principles for brain volume regulation and preserved microcirculation. Crit Care Med 1998;26:1881–6
63. Naredi S, Eden E, Zall S, Stephensen H, Rydenhag B. A standardized neurosurgical neurointensive therapy directed toward vasogenic edema after severe traumatic brain injury: clinical results. Intensive Care Med 1998;24:446–51
64. Naredi S, Olivecrona M, Lindgren C, Ostlund AL, Grande PO, Koskinen LO. An outcome study of severe traumatic head injury using the “Lund therapy” with low-dose prostacyclin. Acta Anaesthesiol Scand 2001;45:402–6
65. Marmarou A, Saad A, Aygok G, Rigsbee M. Contribution of raised ICP and hypotension to CPP reduction in severe brain injury: correlation to outcome. Acta Neurochir Suppl 2005;95:277–80
66. Struchen MA, Hannay HJ, Contant CF, Robertson CS. The relation between acute physiological variables and outcome on the Glasgow Outcome Scale and Disability Rating Scale following severe traumatic brain injury. J Neurotrauma 2001;18:115–25
67. Changaris DG, McGraw CP, Richardson JD, Garretson HD, Arpin EJ, Shields CB. Correlation of cerebral perfusion pressure and Glasgow Coma Scale to outcome. J Trauma 1987;27:1007–13
68. Chesnut RM, Marshall LF, Klauber MR, Blunt BA, Baldwin N, Eisenberg HM, Jane JA, Marmarou A, Foulkes MA. The role of secondary brain injury in determining outcome from severe head injury. J Trauma 1993;34:216–22
69. Fearnside MR, Cook RJ, McDougall P, McNeil RJ. The Westmead Head Injury Project outcome in severe head injury. A comparative analysis of pre-hospital, clinical and CT variables. Br J Neurosurg 1993;7:267–79
70. Manley G, Knudson MM, Morabito D, Damron S, Erickson V, Pitts L. Hypotension, hypoxia, and head injury: frequency, duration, and consequences. Arch Surg 2001;136:1118–23
71. Pigula FA, Wald SL, Shackford SR, Vane DW. The effect of hypotension and hypoxia on children with severe head injuries. J Pediatr Surg 1993;28:310–14
72. Andrews PJ, Sleeman DH, Statham PF, McQuatt A, Corruble V, Jones PA, Howells TP, Macmillan CS. Predicting recovery in patients suffering from traumatic brain injury by using admission variables and physiological data: a comparison between decision tree analysis and logistic regression. J Neurosurg 2002;97:326–36
73. Bruce DA, Langfitt TW, Miller JD, Schutz H, Vapalahti MP, Stanek A, Goldberg HI. Regional cerebral blood flow, intracranial pressure, and brain metabolism in comatose patients. J Neurosurg 1973;38:131–44
74. Clifton GL, Allen S, Barrodale P, Plenger P, Berry J, Koch S, Fletcher J, Hayes RL, Choi SC. A phase II study of moderate hypothermia in severe brain injury. J Neurotrauma 1993;10:263–71
75. Marion DW, Obrist WD, Carlier PM, Penrod LE, Darby JM. The use of moderate therapeutic hypothermia for patients with severe head injuries: a preliminary report. J Neurosurg 1993;79:354–62
76. McGraw CP. A cerebral perfusion pressure greater than 80 mm Hg is more beneficial. Berlin: Springer-Verlag, 1989
77. Rosner MJ, Daughton S. Cerebral perfusion pressure management in head injury. J Trauma 1990;30:933–40
78. Yoshida A, Shima T, Y. O. Outcome of patients with severe head injury-evaluation by cerebral perfusion pressure. Hong Kong: Springer-Verlag, 1993
79. Robertson CS, Valadka AB, Hannay HJ, Contant CF, Gopinath SP, Cormio M, Uzura M, Grossman RG. Prevention of secondary ischemic insults after severe head injury. Crit Care Med 1999;27:2086–95
80. Contant CF, Valadka AB, Gopinath SP, Hannay HJ, Robertson CS. Adult respiratory distress syndrome: a complication of induced hypertension after severe head injury. J Neurosurg 2001;95:560–8
81. Juul N, Morris GF, Marshall SB, Marshall LF. Intracranial hypertension and cerebral perfusion pressure: influence on neurological deterioration and outcome in severe head injury. The executive committee of the international Selfotel trial. J Neurosurg 2000;92:1–6
82. Bouma GJ, Muizelaar JP. Relationship between cardiac output and cerebral blood flow in patients with intact and with impaired autoregulation. J Neurosurg 1990;73:368–74
83. Balestreri M, Czosnyka M, Hutchinson P, Steiner LA, Hiler M, Smielewski P, Pickard JD. Impact of intracranial pressure and cerebral perfusion pressure on severe disability and mortality after head injury. Neurocrit Care 2006;4:8–13
84. Downard C, Hulka F, Mullins RJ, Piatt J, Chesnut R, Quint P, Mann NC. Relationship of cerebral perfusion pressure and survival in pediatric brain-injured patients. J Trauma 2000;49:654–8
85. Elias-Jones AC, Punt JA, Turnbull AE, Jaspan T. Management and outcome of severe head injuries in the Trent region 1985–90. Arch Dis Child 1992;67:1430–5
86. Kaiser G, Pfenninger J. Effect of neurointensive care upon outcome following severe head injuries in childhood–a preliminary report. Neuropediatrics 1984;15:68–75
87. Wahlstrom MR, Olivecrona M, Koskinen LO, Rydenhag B, Naredi S. Severe traumatic brain injury in pediatric patients: treatment and outcome using an intracranial pressure targeted therapy–the Lund concept. Intensive Care Med 2005;31:832–9
88. Adelson PD, Bratton SL, Carney NA, Chesnut RM, du Coudray HE, Goldstein B, Kochanek PM, Miller HC, Partington MD, Selden NR, Warden CR, Wright DW. Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents. Chapter 8. Cerebral perfusion pressure. Pediatr Crit Care Med 2003;4:S31—S33
89. Huang SJ, Hong WC, Han YY, Chen YS, Wen CS, Tsan YS, Tu YK. Clinical outcome of severe head injury in different protocol-driven therapies. J Clin Neurosci 2007;14:449–54
90. Knoller N, Levi L, Shoshan I, Reichenthal E, Razon N, Rappaport ZH, Biegon A. Dexanabinol (HU-211) in the treatment of severe closed head injury: a randomized, placebo-controlled, phase II clinical trial. Crit Care Med 2002;30:548–54
91. Maas AI, Murray G, Henney H 3rd, Kassem N, Legrand V, Mangelus M, Muizelaar JP, Stocchetti N, Knoller N. Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial. Lancet Neurol 2006;5:38–45
92. Cooper DJ, Myles PS, McDermott FT, Murray LJ, Laidlaw J, Cooper G, Tremayne AB, Bernard SS, Ponsford J. Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. JAMA 2004;291:1350–7